In addition, about 13% of those who took the drug had "altered skin sensation" such as tingling or extra sensitivity
It may also show some antihyperlipidemic, antihypertensive, and endothelial-protecting effects
Clinical trials consistently show that Wegovy leads to greater average weight loss compared to other forms of semaglutide, including Ozempic and Rybelsus, which are primarily used as diabetes drugs to help control blood sugar levels in patients with type 2 diabetes
[1] [2] Like all medications, Zepbound carries a profile of potential adverse effects that patients and clinicians should understand before initiating therapy
Patients who qualify for tirzepatide often appreciate its ability to support sustained weight loss while helping improve eating behaviors
The decision involves weighing 60-80% cost savings against lack of regulatory oversight and assuming personal responsibility for quality verification